InsiderTrades.com logo
Healthcare Takes A Big Step Forward With The Help Of AI
From The Bull Report   |   Ad
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Click here to see why this small company is trusted by the Mayo Clinic

SPRY Insider Trading

Insider Ownership Percentage: 35.60%
Insider Buying (Last 12 Months): $40,493,745.66
Insider Selling (Last 12 Months): $6,889,393.59

ARS Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at ARS Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ARS Pharmaceuticals Share Price & Price History

Current Price: $8.44
Price Change: ▲ Price Increase of +0.09 (1.08%)
As of 04/29/2024 11:02 AM ET

This chart shows the closing price history over time for SPRY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Did You Get Your Free Bitcoin Yet?
From Crypto Swap Profits   |   Ad
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
>> Register right here

ARS Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2024Sarina TanimotoInsiderSell100,000$9.28$928,000.001,647,447View SEC Filing Icon  
4/9/2024Richard E LowenthalCEOSell100,000$9.28$928,000.001,646,494View SEC Filing Icon  
3/27/2024Ra Capital Management, L.P.DirectorBuy505,954$9.79$4,953,289.669,958,073View SEC Filing Icon  
3/25/2024Ra Capital Management, L.P.DirectorBuy437,600$9.06$3,964,656.008,994,374View SEC Filing Icon  
3/25/2024Richard E LowenthalCEOSell95,267$9.12$868,835.041,697,447View SEC Filing Icon  
3/22/2024Sarina TanimotoInsiderSell2,343$9.02$21,133.861,745,082View SEC Filing Icon  
3/21/2024Richard E LowenthalCEOSell472$9.00$4,248.001,746,099View SEC Filing Icon  
3/19/2024Richard E LowenthalCEOSell1,918$9.03$17,319.541,746,471View SEC Filing Icon  
3/15/2024Richard E LowenthalCEOSell96,756$9.14$884,349.841,696,494View SEC Filing Icon  
3/14/2024Sarina TanimotoInsiderSell444$9.00$3,996.001,744,789View SEC Filing Icon  
3/13/2024Richard E LowenthalCEOSell2,800$9.00$25,200.001,744,994View SEC Filing Icon  
2/29/2024Richard E LowenthalCEOSell3,782$9.02$34,113.641,746,494View SEC Filing Icon  
2/28/2024Sarina TanimotoInsiderSell98,778$9.02$890,977.561,747,294View SEC Filing Icon  
2/26/2024Sarina TanimotoInsiderSell700$9.01$6,307.001,772,750View SEC Filing Icon  
9/28/2023Alexander A FitzpatrickInsiderBuy40,000$3.62$144,800.0042,969View SEC Filing Icon  
9/21/2023Ra Capital Management, L.P.DirectorBuy2,700,000$3.03$8,181,000.008,556,774View SEC Filing Icon  
9/1/2023Laura ShawverDirectorSell100,000$7.71$771,000.00210,346View SEC Filing Icon  
8/29/2023Ra Capital Management, L.P.DirectorBuy3,750,000$6.20$23,250,000.005,856,774View SEC Filing Icon  
8/4/2023Laura ShawverDirectorSell18,897$7.06$133,412.82210,346View SEC Filing Icon  
8/2/2023Laura ShawverDirectorSell36,281$7.09$257,232.29210,346View SEC Filing Icon  
7/6/2023Laura ShawverDirectorSell33,510$6.34$212,453.40210,346View SEC Filing Icon  
7/3/2023Laura ShawverDirectorSell26,520$6.72$178,214.40210,346View SEC Filing Icon  
6/1/2023Laura ShawverDirectorSell73,059$6.80$496,801.20210,346View SEC Filing Icon  
5/9/2023Laura ShawverDirectorSell42,900$5.31$227,799.00210,346View SEC Filing Icon  
11/29/2022Kathleen D ScottCFOBuy8,250$6.24$51,480.008,250View SEC Filing Icon  
See Full Table
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
From True Market Insiders   |   Ad
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Click For My #1 FREE Crypto for 2024

SEC Filings (Institutional Ownership Changes) for ARS Pharmaceuticals (NASDAQ:SPRY)

68.16% of ARS Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SPRY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ARS Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2024Sectoral Asset Management Inc.354,641$1.94M0.8%-66.2%0.369%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 7,065$39K0.0%-80.2%0.007%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.4,098,497$22.46M0.0%+5.9%4.269%Search for SEC Filing on Google Icon
2/6/2024AJOVista LLC7,822$43K0.1%N/A0.008%Search for SEC Filing on Google Icon
2/6/2024Levin Capital Strategies L.P.52,250$0.29M0.0%-61.0%0.054%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank66,000$0.36M0.0%-19.8%0.069%Search for SEC Filing on Google Icon
1/25/2024Nisa Investment Advisors LLC5,600$31K0.0%+22,300.0%0.006%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.11,105$61K0.0%+352.7%0.012%Search for SEC Filing on Google Icon
1/19/2024Denali Advisors LLC87,500$0.48M0.1%N/A0.091%Search for SEC Filing on Google Icon
1/10/2024Charles Schwab Trust Co3,996,071$21.90M2.2%-5.9%4.163%Search for SEC Filing on Google Icon
11/15/2023Tejara Capital Ltd103,739$0.39M0.2%-22.3%0.108%Search for SEC Filing on Google Icon
11/15/2023RA Capital Management L.P.9,459,678$35.76M0.7%+214.3%9.854%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.1,049,191$3.97M0.8%-16.4%1.093%Search for SEC Filing on Google Icon
11/14/2023Rubric Capital Management LP639,203$2.42M0.1%-77.2%0.666%Search for SEC Filing on Google Icon
11/13/2023FMR LLC1,307,340$4.94M0.0%-72.0%1.362%Search for SEC Filing on Google Icon
11/13/2023Tejara Capital Ltd103,739$0.39M0.3%-22.3%0.108%Search for SEC Filing on Google Icon
11/9/2023Letko Brosseau & Associates Inc.36,000$0.14M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/8/2023Janney Montgomery Scott LLC24,072$91K0.0%-39.8%0.025%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp83,924$0.32M0.0%+9.1%0.088%Search for SEC Filing on Google Icon
10/23/2023FAS Wealth Partners Inc.45,970$0.17M0.0%+34.2%0.048%Search for SEC Filing on Google Icon
10/20/2023Charles Schwab Trust Co4,246,071$16.05M1.8%N/A4.443%Search for SEC Filing on Google Icon
10/12/2023Brendel Financial Advisors LLC19,125$72K0.1%N/A0.020%Search for SEC Filing on Google Icon
10/11/2023Vontobel Holding Ltd.260,684$0.99M0.0%-24.2%0.273%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC20,460$0.14M0.0%N/A0.021%Search for SEC Filing on Google Icon
8/14/2023Caption Management LLC73,400$0.49M0.0%N/A0.077%Search for SEC Filing on Google Icon
8/11/2023Sectoral Asset Management Inc.1,255,640$8.41M1.4%N/A1.325%Search for SEC Filing on Google Icon
8/11/2023Rubric Capital Management LP2,799,203$18.76M0.8%-19.6%2.954%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd133,521$0.90M0.4%N/A0.141%Search for SEC Filing on Google Icon
8/10/2023Nicholas Investment Partners LP275,000$1.84M0.1%N/A0.290%Search for SEC Filing on Google Icon
8/8/2023FAS Wealth Partners Inc.34,250$0.23M0.0%N/A0.036%Search for SEC Filing on Google Icon
8/7/2023Royce & Associates LP463,700$3.11M0.0%+52.6%0.489%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.11,672$78K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/1/2023Arizona State Retirement System10,606$71K0.0%N/A0.011%Search for SEC Filing on Google Icon
7/31/2023Levin Capital Strategies L.P.169,074$1.13M0.1%N/A0.178%Search for SEC Filing on Google Icon
7/28/2023Shell Asset Management Co.65,322$0.44M0.0%N/A0.069%Search for SEC Filing on Google Icon
7/26/2023Janney Montgomery Scott LLC39,969$0.27M0.0%N/A0.042%Search for SEC Filing on Google Icon
7/25/2023DekaBank Deutsche Girozentrale35,000$0.23M0.0%N/A0.037%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.344,029$2.31M0.0%N/A0.363%Search for SEC Filing on Google Icon
7/19/2023Teacher Retirement System of Texas10,244$69K0.0%N/A0.011%Search for SEC Filing on Google Icon
7/18/2023Avantax Planning Partners Inc.32,174$0.22M0.0%N/A0.034%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC15,053$98K0.0%N/A0.016%Search for SEC Filing on Google Icon
5/23/2023Royce & Associates LP303,900$1.98M0.0%N/A0.321%Search for SEC Filing on Google Icon
5/19/2023SR One Capital Management LP4,012,903$26.12M8.9%N/A4.234%Search for SEC Filing on Google Icon
5/16/2023Baker BROS. Advisors LP2,006,451$13.06M0.1%N/A2.121%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ARS Pharmaceuticals logo
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Read More on ARS Pharmaceuticals

Today's Range

Now: $8.44
Low: $8.41
High: $8.52

50 Day Range

MA: $8.87
Low: $7.17
High: $10.22

52 Week Range

Now: $8.44
Low: $2.55
High: $11.27

Volume

20,489 shs

Average Volume

602,736 shs

Market Capitalization

$814.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of ARS Pharmaceuticals?

ARS Pharmaceuticals' top insider shareholders include:
  1. Ra Capital Management, LP (Director)
  2. Sarina Tanimoto (Insider)
  3. Richard E Lowenthal (CEO)
  4. Laura Shawver (Director)
  5. Alexander A Fitzpatrick (Insider)
  6. Kathleen D Scott (CFO)
Learn More about top insider investors at ARS Pharmaceuticals.

Who are the major institutional investors of ARS Pharmaceuticals?

ARS Pharmaceuticals' top institutional shareholders include:
  1. Simplex Trading LLC — 0.00%
Learn More about top institutional investors of ARS Pharmaceuticals stock.

Which major investors are selling ARS Pharmaceuticals stock?

In the last quarter, SPRY stock was sold by these institutional investors:
  1. Simplex Trading LLC
In the last year, company insiders that have sold ARS Pharmaceuticals company stock include:
  1. Ra Capital Management, LP (Director)
  2. Sarina Tanimoto (Insider)
  3. Richard E Lowenthal (CEO)
Learn More investors selling ARS Pharmaceuticals stock.
Healthcare Takes A Big Step Forward With The Help Of AI
From The Bull Report   |   Ad
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Click here to see why this small company is trusted by the Mayo Clinic